Redundancies in T cells

.
Cancer immunotherapy enables T cells (front) to attack and eliminate tumour cells (dark red). (Visualisations: Shutterstock)

Researchers at ETH Zurich have discovered redundancies in the biochemical signalling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas.

ETH-News

Helen Stauffer

News